Cargando…
Reactogenicity and safety of the human rotavirus vaccine, Rotarix™ in The Philippines, Sri Lanka, and India: A post-marketing surveillance study
Regulatory bodies in The Philippines, Sri Lanka, and India require post-marketing surveillance to provide additional safety data on Rotarix™ in real-life settings. In such studies conducted in The Philippines (November 2006 to July 2012; NCT00353366), Sri Lanka (November 2008 to August 2009; NCT0077...
Autores principales: | Bravo, Lulu, Chitraka, Amarjeet, Liu, Aixue, Choudhury, Jaydeep, Kumar, Kishore, Berezo, Lennie, Cimafranca, Leonard, Chatterjee, Pallab, Garg, Pankaj, Siriwardene, Prasanna, Bernardo, Rommel, Mehta, Shailesh, Balasubramanian, Sundaram, Karkada, Naveen, Htay Han, Htay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4896787/ https://www.ncbi.nlm.nih.gov/pubmed/25424932 http://dx.doi.org/10.4161/hv.29280 |
Ejemplares similares
-
The human rotavirus vaccine Rotarix™ in infants: An integrated analysis of safety and reactogenicity
por: Buyse, Hubert, et al.
Publicado: (2014) -
Post-marketing safety surveillance conducted in Korea (2008–2013) following the introduction of the rotavirus vaccine, RIX4414 (Rotarix™)
por: Shin, Son Moon, et al.
Publicado: (2016) -
Serologic response to porcine circovirus type 1 (PCV1) in infants vaccinated with the human rotavirus vaccine, Rotarix™: A retrospective laboratory analysis
por: Han, Htay Htay, et al.
Publicado: (2016) -
Reactogenicity and safety of a liquid human rotavirus vaccine (RIX4414) in healthy adults, children and infants in China: Randomized, double-blind, placebo-controlled Phase I studies
por: Li, Rong-Cheng, et al.
Publicado: (2013) -
Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial
por: Steele, Andrew Duncan, et al.
Publicado: (2012)